Premium
Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats
Author(s) -
Philipp Sebastian,
Jürgensen Jan Steffen,
Fielitz Jens,
Bernhardt Wanja M.,
Weidemann Alexander,
Schiche Astrid,
Pilz Bernhard,
Dietz Rainer,
RegitzZagrosek Vera,
Eckardt KaiUwe,
Willenbrock Roland
Publication year - 2006
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2005.10.009
Subject(s) - medicine , myocardial infarction , hypoxia (environmental) , endocrinology , heart failure , contractility , hydroxylation , hypoxia inducible factors , osteopontin , ejection fraction , growth factor , cardiac function curve , ventricular remodeling , ctgf , infarction , enzyme , chemistry , biochemistry , receptor , organic chemistry , oxygen , gene
Prolyl hydroxylase domain‐containing enzymes (PHD) hydroxylate a proline residue that controls the degradation of hypoxia inducible factor (HIF). Hypoxia inhibits this hydroxylation thus increasing HIF levels. HIF is upregulated in ischemic tissues, growing tumors and in nonischemic, mechanically stressed myocardium. Pharmacological inhibition of prolyl 4‐hydroxylase (P4‐H) stabilizes HIF‐protein in vitro and may modulate collagen turnover. The aims of this study were to investigate whether inhibition of P4‐H protects myocardium against ischemia, and whether the observed effects are related to modulation of collagen metabolism or due to the stabilization of HIF. Methods: Rats were treated with a specific P4‐H inhibitor (P4‐HI) or vehicle starting 2 days before induction of myocardial infarction (MI). Rats were investigated 7 or 30 days after MI. Induction of HIF‐1α and −2α was visualized by immunohistochemistry. Expression of growth factors (connective tissue growth factor, Osteopontin) and mRNA expression and protein levels of Collagen I and III as well as HIF‐2α were measured. Results: P4‐HI augments HIF in the myocardium as early as 24 h after treatment. P4‐HI did not alter the MI‐induced enhanced expression of growth factors and collagen. Treatment with P4‐HI significantly reduced heart and lung weight, improved left ventricular contractility, prevented left ventricular enlargement and improved left ventricular ejection fraction without affecting infarct size after 30 days. Conclusions: Specific inhibition of the P4‐H improved cardiac function without affecting the infarct size after experimental myocardial infarction in rats. Stabilization of HIF rather than inhibition of collagen maturation by P4‐HI may prevent cardiac remodeling after MI.